Simplex Trading, LLC Sellas Life Sciences Group, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$2.02 - $3.38 $2,656 - $4,444	1,315 New	1,315 $2,000
Q2 2022 Aug 03, 2022	SELL	$2.14 - $4.15 $14,791 - $28,684	-6,912 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$4.73 - $7.18 $170 - $258	-36 Reduced 0.52%	6,912 $46,000
Q4 2021 Feb 23, 2022	BUY	$5.36 - $9.53 $37,241 - $66,214	6,948 New	6,948 $38,000
Q1 2021 Apr 26, 2021	SELL	$5.5 - $11.71 $88 - $187	-16 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$2.45 - $17.66 $39 - $282	16 New	16 $0

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.